Ligand Pharmaceuticals (LGND) Net Equity Issued and Repurchased (2010 - 2024)
Ligand Pharmaceuticals (LGND) reported Net Equity Issued and Repurchased of $3.1 million for Q4 2024, up 156.55% sequentially from -$5.5 million in Q4 2013.
Ligand Pharmaceuticals (LGND) Net Equity Issued and Repurchased (2010 - 2024) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $3.1 million in Q4 2024.
- For the quarter ending Q4 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2025 stood at -$2.4 million (down 3050.62% YoY), and the FY2024 full-year result was $37.1 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased advanced to $3.1 million in Q4 2024, from -$5.5 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $3.1 million in Q4 2024 to a low of $3.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.11 Mn |
| Dec 31, 2024 | 3.11 Mn |
| Dec 31, 2013 | -5.50 Mn |
| Dec 31, 2013 | -5.50 Mn |
| Dec 31, 2012 | 2.47 Mn |
| Dec 31, 2012 | 2.47 Mn |
| Sep 30, 2012 | 2.60 Mn |
| Sep 30, 2012 | 2.60 Mn |
| Jun 30, 2012 | 82,000.00 |
| Jun 30, 2012 | 82,000.00 |
| Mar 31, 2012 | 160,000.00 |
| Mar 31, 2012 | 160,000.00 |
| Dec 31, 2011 | -2,000.00 |
| Dec 31, 2011 | -2,000.00 |
| Sep 30, 2011 | 2,000.00 |
| Sep 30, 2011 | 2,000.00 |
| Dec 31, 2010 | -87,000.00 |
| Dec 31, 2010 | -87,000.00 |
| Sep 30, 2010 | -2,000.00 |
| Sep 30, 2010 | -2,000.00 |